Not Yet Recruiting INTERVENTIONAL NCT07282002

Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis (PAVE)

Feasibility Protocol for Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis

Sponsor: Angiodynamics, Inc.

Conditions Infective Endocarditis (IE)

Interventions AngioVac System

Updated 2 times since 2026 Last updated: Apr 17, 2026 Started: Apr 1, 2026 Primary completion: Nov 1, 2026 Completion: Mar 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Infective Endocarditis (IE) and is currently actively recruiting participants. Angiodynamics, Inc. leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Study Description(click to expand)

This is a prospective, multicenter, single-arm investigational device study evaluating safety and effectiveness.

Status Flow

Change History

2 versions recorded

Apr 23, 2026 — Present [daily]

Not Yet Recruiting

Phase: NA → None
Jan 2026 — Apr 2026 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

The investigation aims to demonstrate initial safety and efficacy of the AngioVac System for the removal of vegetation in the right heart in patients with infective endocarditis.

Contact Information

Sponsor contact:

Angiodynamics, Inc.

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.